QQ客服 官方微博 反馈留言

	Multi-center randomized phase II trial of pemetrexed plus oxaliplatin or pemetrexed alone as the second line treatment for stage IV non-squamous non-small cell lung cancer
	Lu, Y.; Gong, Y.; Ren, L.; Huang, M.; Li, L.; Peng, F.; Hou, M.; Li, W.; Jia, Y.; Yang, H.
刊名	EUROPEAN JOURNAL OF CANCER
	2013
卷号	49
ISSN号	0959-8049
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3448750
专题	昆明医科大学
推荐引用方式 GB/T 7714	Lu, Y.,Gong, Y.,Ren, L.,et al. Multi-center randomized phase II trial of pemetrexed plus oxaliplatin or pemetrexed alone as the second line treatment for stage IV non-squamous non-small cell lung cancer[J]. EUROPEAN JOURNAL OF CANCER,2013,49.
APA	Lu, Y..,Gong, Y..,Ren, L..,Huang, M..,Li, L..,...&Yang, H..(2013).Multi-center randomized phase II trial of pemetrexed plus oxaliplatin or pemetrexed alone as the second line treatment for stage IV non-squamous non-small cell lung cancer.EUROPEAN JOURNAL OF CANCER,49.
MLA	Lu, Y.,et al."Multi-center randomized phase II trial of pemetrexed plus oxaliplatin or pemetrexed alone as the second line treatment for stage IV non-squamous non-small cell lung cancer".EUROPEAN JOURNAL OF CANCER 49(2013).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。